Prakt. lékáren. 2012; 8(3): 126-129

Blood pressure measurement in pharmacies in the Czech Republic - analysis of the pilot study

Josef Malý, Martin Doseděl
Katedra sociální a klinické farmacie, Farmaceutická fakulta UK, Hradec Králové

High prevalence of arterial hypertension performs severe health problem in developed countries and in many patients hypertension

is not early detected and started an adequate treatment. Poor treatment compensation of diseases related to hypertension is in many

cases associated with a high degree of non-adherence to therapy. Experience show progress in this situation by force of pharmacy counselling

services and screening focused on patients with hypertension. This paper presents current state of blood pressure measurement

in a sample of Czech pharmacies and authors discuss potential development and limits of this professional activity in pharmacies.

service.

Keywords: arterial hypertension, blood pressure measurement, space and material equipment of pharmacy, pharmaceutical care

Published: May 14, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malý J, Doseděl M. Blood pressure measurement in pharmacies in the Czech Republic - analysis of the pilot study. Farmacie pro praxi. 2012;8(3):126-129.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21(6): 1011-1053.
    2. Widimský J jr, Cífková R, Špinar J. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Doporučení České společnosti pro hypertenzi. Cor Vasa 2008; 50(1): K5-K22.
    3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42(6): 1206-1252. Go to original source... Go to PubMed...
    4. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005; 112(11): 1651-1662. Go to original source... Go to PubMed...
    5. Coca A, Aranda P, Bertomeu V, et al. Strategies for effective control of arterial hypertension in Spain. Consensus document. Rev Clin Esp 2006; 206(10): 510-514. Go to original source... Go to PubMed...
    6. Zillich AJ, Sutherland JM, Kumbera PA, et al. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med 2005; 20(12): 1091-1096. Go to original source... Go to PubMed...
    7. Peleška J. Domácí měření krevního tlaku. Med Pro Praxi 2006; 3: 111-114.
    8. Walsh JM, Sundaram V, McDonald K, et al. Implementing effective hypertension quality improvement strategies: barriers and potential solutions. J Clin Hypertens (Greenwich) 2008; 10(4): 311-316. Go to original source... Go to PubMed...
    9. Herber O, Widimský J jr. Metodické doporučení pro domácí měření krevního tlaku. Postgrad med 2011; 13(příl. 4): 13-16.
    10. Berenguer B, La Casa C, de la Matta MJ, et al. Pharmaceutical Care: Past, Present and Future. Curr Pharm Des 2004; 10: 3931-3946. Go to original source... Go to PubMed...
    11. Kolář J, Macešková B. Současné přístupy k farmakoterapii - farmaceutická péče nebo management léků? Ceska Slov Farm 2010; 59: 7-10.
    12. Česká lékárnická komora. Doporučené postupy České lékárnické komory pro konzultační činnost v lékárnách, Solen 2010; 168 s.
    13. Malý J, Opavová T, Vlček J, et al. Bariéry a možnosti dalšího rozvoje konzultační činnosti v lékárnách v České republice. Prakt lékáren 2012; 8(1): 31-33.
    14. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci 2008; 30(1): 128-135. Go to original source... Go to PubMed...
    15. de Castro MS, Fuchs FD, Santos MC, et al. Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring. Am J Hypertens 2006; 19(5): 528-533. Go to original source... Go to PubMed...
    16. Aguiar PM, Balisa-Rocha BJ, Brito GD, et al. Pharmaceutical care in hypertensive patients: A systematic literature review. Res Social Adm Pharm 2012 Jan 3. In press. Go to original source... Go to PubMed...
    17. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41(11): 1770-1781. Go to original source... Go to PubMed...
    18. Zdravotnictví České republiky 2010 ve statistických údajích. Ústav zdravotnických informací a statistiky České republiky. [online]. Srpen 2011. [cit. 2012-01-17]. Dostupné z: <http://www.uzis.cz/system/files/kardcz2010.pdf>.
    19. Němcová H. Měření krevního tlaku. Prakt lékáren 2009; 5(5): 242-247.
    20. Vlček J, Fialová D, et al. Klinická farmacie I. Praha: Grada Publishing 2010: 368 s.
    21. Vlček J. Lékové interakce z pohledu klinického farmaceuta. Practicus 2009; 8: 10-15.
    22. Rudolf K, Malý J, Vlček J. Problematika potenciálních lékových interakcí v kardiologii očima farmaceuta při výdeji léčiv. Prakt lékáren 2008; 4(1): 21-23.
    23. Malý J, Rudolf K, Vlček J. Úloha farmaceuta při bezpečném podávání nesteroidních antirevmatik. Prakt lékáren 2008; 4(2): 82-85.
    24. Rudolf K, Malý J. Co by měl lékárník vědět o lékových interakcích a nežádoucích účincích kardiovaskulární terapie. Prakt lékáren 2010; 6(5): 240-243.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.